Zanubrutinib, Obinutuzumab and Lenalidomide (ZGR) in High-risk Treatment-naive Patients with Follicular Lymphoma (FL)
Clinical trial NCT06549335 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06549335
- Sponsor
- Ruijin Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-01
- Primary completion
- 2026-12-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.